Mölnlycke Health Care, a leading MedTech company, has increased its stake in Tamer Mölnlycke Care from 33.3% to 60%, becoming the majority shareholder. This joint venture with Tamer Group, initiated in 2021, aims to expand the range of products manufactured in Saudi Arabia, including surgical procedure trays and various wound care solutions. The investment aligns with Saudi Vision 2030 to foster regional healthcare growth and develop local skills. Both companies’ leadership emphasized the strategic importance of this expansion to meet growing healthcare demands in the Middle East and Africa. First production at the joint venture’s new factory is expected in Q4 2024.

Healthcare, Medical Technology (MedTech), Manufacturing,Saudi Arabia, Middle East, Africa